Skip to main content
Professional Technical IVT

PIMS-TS

Pronunciation: PIMS-T-S

Also written as: PIMS-TS — Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2

Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2, a severe post-infectious inflammatory condition.

Full Definition

A rare but serious condition affecting children and adolescents weeks after SARS-CoV-2 infection, characterized by fever and multiorgan dysfunction. PIMS-TS presents with features similar to Kawasaki disease, toxic shock syndrome, or macrophage activation syndrome. Critical care management focuses on cardiovascular support, anti-inflammatory therapy with corticosteroids or IVIG, and monitoring for cardiac complications including coronary artery abnormalities and myocarditis.

Usage

Usage note: UK terminology; equivalent to MIS-C in US literature. Always capitalize.

In Context

  • "The patient met criteria for PIMS-TS with fever, rash, and elevated inflammatory markers following recent COVID-19 infection." — Diagnostic evaluation
  • "Echocardiography was performed to assess for cardiac involvement in suspected PIMS-TS." — Cardiac monitoring protocol

Also known as

MIS-C multisystem inflammatory syndrome in children

Don't confuse with

Kawasaki disease toxic shock syndrome

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON